Clinical Trials Directory

Trials / Completed

CompletedNCT00779753

Determination of Lysine Requirement in the Parenterally Fed Neonate

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to establish the parenteral lysine requirements for neonates.

Detailed description

It is important to identify the appropriate level of lysine requirements for parenterally fed neonates as this amino acid is the limiting amino acid in the diet of neonates. Feeding lysine at requirement improves the likelihood that other amino acids will be utilized appropriately for building proteins. In addition, lysine plays a major role in calcium absorption, development of muscle proteins and in the production of hormones, enzymes and antibodies. We believe that the lysine requirement will be 158 mg/kg/day which is significantly lower than the current 267 and 327 mg/kg/d that is found in the current Trophamine and Primene parenteral solutions.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAmino Acid Solution with different amount of LysineThe infants will be placed on a standard Primene solution for the first 24 hours of the study to obtain baseline values. During the second 24 hours they will receive an amino acid solution that has a different amount of lysine currently found in Primene, all lipid, CHO, minerals, vitamins and trace elements will remain unchanged. The Parenteral lysine will be studied at the following intake levels: 100, 110, 120, 130, 135, 140, 145, 150 , 155, 165, 170, 180, 200, 230, 245, 260mg/kg/d. The minimum energy intake will be 85-90 kcal/kg/day.

Timeline

Start date
2008-07-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2008-10-24
Last updated
2013-08-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00779753. Inclusion in this directory is not an endorsement.